Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$292K Sell
4,644
-4,550
-49% -$265K 0.01% 1703
2017
Q1
$470K Sell
9,194
-2,355
-20% -$112K 0.01% 1435
2016
Q4
$492K Sell
11,549
-5,727
-33% -$244K 0.01% 1509
2016
Q3
$820K Buy
+17,276
New +$862K 0.02% 880

Other funds holding AMED

Virtu KCG Holdings's AMED Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Amedisys (AMED) stake by 49% in Q2 2017, selling an estimated $265K and leaving 4,644 shares worth $292K. The position accounts for 0.01% of the portfolio, ranked #1703.

Virtu KCG Holdings first reported a position in AMED in Q3 2016 and has held it in 4 quarters since. The position peaked at $820K in Q3 2016. 169 funds tracked by Wall St. Rank hold AMED as of Q2 2017.

  • Virtu KCG Holdings held 4,644 shares of Amedisys worth $292K as of Q2 2017.
  • Virtu KCG Holdings sold 4,550 Amedisys shares in Q2 2017, an estimated $265K.
  • Amedisys made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1703 holding.
  • Virtu KCG Holdings first reported a position in Amedisys in Q3 2016 and has held it in 4 quarters since.
  • Virtu KCG Holdings's Amedisys position peaked at $820K in Q3 2016.
  • 169 funds tracked by Wall St. Rank held Amedisys as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.